Search research articles
Contact Us
Filters
Showing results (51-60 of 60) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 60 results.
Ophthalmology
|
June 1, 2005
Full-thickness macular hole after LASIK for the correction of myopia
J Fernando Arevalo, Aristides J Mendoza, Wandsy Velez-Vazquez, et al.
Breast Cancer Research : BCR
|
April 15, 2014
Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2- breast cancer patients: results from the GEICAM 9906 trial
Miguel Martin, Jan C Brase, Lourdes Calvo, et al.
Breast Cancer Research and Treatment
|
February 25, 2016
Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study
Miguel Martin, Jan C Brase, Amparo Ruiz, et al.
European Journal of Hospital Pharmacy : Science and Practice
|
February 18, 2020
The economic burden of metastatic breast cancer in Spain
Begoña Bermejo de Las Heras, Javier Cortes Ramon Y Cajal, Elena Galve Calvo, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
July 30, 2025
Revisiting Alma Ata: A Blueprint for Cancer Care
Javier-David Benitez-Fuentes, Rodrigo Lastra Del Prado, Miguel Borregon-Rivilla, et al.
The New England Journal of Medicine
|
June 2, 2025
Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer
Mario Campone, Michelino De Laurentiis, Komal Jhaveri, et al.
The Oncologist
|
April 25, 2015
Defining breast cancer intrinsic subtypes by quantitative receptor expression
Maggie C U Cheang, Miguel Martin, Torsten O Nielsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 26, 2026
Sensitivity to endocrine therapy index predicts benefit from weekly adjuvant paclitaxel for hormone receptor-positive breast cancer in the GEICAM/9906 trial
Miguel Martín, Alvaro Rodriguez-Lescure, Cristina Reboredo, et al.
The New England Journal of Medicine
|
June 3, 2005
Adjuvant docetaxel for node-positive breast cancer
Miguel Martin, Tadeusz Pienkowski, John Mackey, et al.
Melanoma Research
|
March 29, 2023
Adjuvant dabrafenib and trametinib for patients with resected BRAF -mutated melanoma: DESCRIBE-AD real-world retrospective observational study
José L Manzano, Juan Martin-Liberal, Luis A Fernández-Morales, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 60) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 60 results.
Ophthalmology
|
June 1, 2005
Full-thickness macular hole after LASIK for the correction of myopia
J Fernando Arevalo, Aristides J Mendoza, Wandsy Velez-Vazquez, et al.
Breast Cancer Research : BCR
|
April 15, 2014
Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2- breast cancer patients: results from the GEICAM 9906 trial
Miguel Martin, Jan C Brase, Lourdes Calvo, et al.
Breast Cancer Research and Treatment
|
February 25, 2016
Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study
Miguel Martin, Jan C Brase, Amparo Ruiz, et al.
European Journal of Hospital Pharmacy : Science and Practice
|
February 18, 2020
The economic burden of metastatic breast cancer in Spain
Begoña Bermejo de Las Heras, Javier Cortes Ramon Y Cajal, Elena Galve Calvo, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
July 30, 2025
Revisiting Alma Ata: A Blueprint for Cancer Care
Javier-David Benitez-Fuentes, Rodrigo Lastra Del Prado, Miguel Borregon-Rivilla, et al.
The New England Journal of Medicine
|
June 2, 2025
Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer
Mario Campone, Michelino De Laurentiis, Komal Jhaveri, et al.
The Oncologist
|
April 25, 2015
Defining breast cancer intrinsic subtypes by quantitative receptor expression
Maggie C U Cheang, Miguel Martin, Torsten O Nielsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 26, 2026
Sensitivity to endocrine therapy index predicts benefit from weekly adjuvant paclitaxel for hormone receptor-positive breast cancer in the GEICAM/9906 trial
Miguel Martín, Alvaro Rodriguez-Lescure, Cristina Reboredo, et al.
The New England Journal of Medicine
|
June 3, 2005
Adjuvant docetaxel for node-positive breast cancer
Miguel Martin, Tadeusz Pienkowski, John Mackey, et al.
Melanoma Research
|
March 29, 2023
Adjuvant dabrafenib and trametinib for patients with resected BRAF -mutated melanoma: DESCRIBE-AD real-world retrospective observational study
José L Manzano, Juan Martin-Liberal, Luis A Fernández-Morales, et al.
Page
of 6